Genetic and structural insights into broad neutralization of hepatitis C virus by human VH1-69 antibodies N Tzarum, E Giang, L Kong, L He, J Prentoe, E Augestad, Y Hua, ... Science Advances 5 (1), eaav1882, 2019 | 78 | 2019 |
Hypervariable region 1 and N-linked glycans of hepatitis C regulate virion neutralization by modulating envelope conformations J Prentoe, R Velázquez-Moctezuma, EH Augestad, A Galli, R Wang, ... Proceedings of the National Academy of Sciences 116 (20), 10039-10047, 2019 | 50 | 2019 |
Global and local envelope protein dynamics of hepatitis C virus determine broad antibody sensitivity EH Augestad, M Castelli, N Clementi, LJ Ströh, T Krey, R Burioni, ... Science Advances 6 (35), eabb5938, 2020 | 34* | 2020 |
An alternate conformation of HCV E2 neutralizing face as an additional vaccine target N Tzarum, E Giang, RU Kadam, F Chen, K Nagy, EH Augestad, ... Science advances 6 (30), eabb5642, 2020 | 26 | 2020 |
Functional convergence of a germline-encoded neutralizing antibody response in rhesus macaques immunized with HCV envelope glycoproteins F Chen, N Tzarum, X Lin, E Giang, R Velázquez-Moctezuma, ... Immunity 54 (4), 781-796. e4, 2021 | 25 | 2021 |
Hepatitis C virus envelope protein dynamics and the link to hypervariable region 1 EH Augestad, J Bukh, J Prentoe Current opinion in virology 50, 69-75, 2021 | 13 | 2021 |
Inactivated whole hepatitis C virus vaccine employing a licensed adjuvant elicits cross-genotype neutralizing antibodies in mice AF Pihl, S Feng, A Offersgaard, GP Alzua, EH Augestad, CK Mathiesen, ... Journal of Hepatology 76 (5), 1051-1061, 2022 | 11 | 2022 |
Mechanisms of hepatitis C virus escape from vaccine-relevant neutralizing antibodies R Velázquez-Moctezuma, EH Augestad, M Castelli, C Holmboe Olesen, ... Vaccines 9 (3), 291, 2021 | 10 | 2021 |
Genetic and structural insights into broad neutralization of hepatitis C virus by human VH1-69 antibodies. Sci Adv 5: eaav1882 N Tzarum, E Giang, L Kong, L He, J Prentoe, E Augestad, Y Hua, ... | 7 | 2019 |
Identification of novel neutralizing determinants for protection against HCV GP Alzua, AF Pihl, A Offersgaard, R Velázquez‐Moctezuma, ... Hepatology 77 (3), 982-996, 2023 | 4 | 2023 |
Antigenic and immunogenic evaluation of permutations of soluble hepatitis C virus envelope protein E2 and E1 antigens J Prentoe, CM Janitzek, R Velázquez-Moctezuma, L Goksøyr, RW Olsen, ... Plos one 16 (7), e0255336, 2021 | 4 | 2021 |
In vitro adaptation and characterization of attenuated hypervariable region 1 swap chimeras of hepatitis C virus CH Olesen, EH Augestad, F Troise, J Bukh, J Prentoe PLoS Pathogens 17 (7), e1009720, 2021 | 4 | 2021 |
Structure of the hepatitis C virus E1/E2 envelope proteins in a homodimeric complex E Augestad, CH Olesen, C Groenberg, A Soerensen, ... bioRxiv, 2023.12. 27.573427, 2023 | | 2023 |
Antigenic and immunogenic evaluation of permutations of soluble hepatitis C virus envelope protein E2 and E1 antigens L Goksøyr, RW Olsen, M Fanalista, EH Augestad, S Thrane, AF Pihl, ... | | 2021 |
In vitro adaptation and characterization of attenuated hypervariable region 1 swap chimeras of hepatitis C virus EH Augestad, F Troise, J Prentoe | | 2021 |
Identification of Novel Determinants of Neutralization Epitope Shielding for Hepatitis C Virus in Vitro GP Alzua, AF Pihl, AF Offersgaard, R Velázquez-Moctezuma, ... Proceedings 50 (1), 5, 2020 | | 2020 |